QUANTIFICATION OF APOLIPOPROTEIN A-IV IN HUMAN PLASMA BY IMMUNONEPHELOMETRY

被引:0
|
作者
SCHWARZ, S
HAAS, B
LULEY, C
SCHAFER, JR
STEINMETZ, A
机构
[1] UNIV MARBURG,ZENTRUM INNERE MED,ENDOKRINOL & STOFFWECHSEL ABT,D-35033 MARBURG,GERMANY
[2] UNIV FREIBURG,KLIN CHEM ABT,D-79106 FREIBURG,GERMANY
关键词
LIPOPROTEINS; ATHEROSCLEROSIS; ELECTROIMMUNODIFFUSION COMPARED; TRIGLYCERIDES; SAMPLE HANDLING;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We developed a nephelometric procedure for determining concentrations of human plasma apolipoprotein (ape) A-IV. Results obtained correlate well with those measured by an established electroimmunodiffusion assay (r = 0.98; n = 56). Intra- and interassay CVs were 2.4% and 2.0%, respectively, indicating excellent precision and reproducibility. Various conditions of sample treatment, such as adequate storage, freezing, and thawing, did not affect results significantly. However, keeping samples at room temperature for 4 days led to a slight increase in measured values. Preincubation with a cholesterinesterase-detergent mixture abolished interference from triglyceride-rich lipoproteins, allowing assay of samples containing triglycerides as great as 10 g/L. The assay is easily applicable to clinical laboratories for routine diagnostic use, as shown with hypertriglyceridemic plasmas and samples with a broad range of apo A-IV concentrations.
引用
收藏
页码:1717 / 1721
页数:5
相关论文
共 50 条
  • [1] Plaque stabilizing effects of apolipoprotein A-IV
    Geronimo, F. R. B.
    Barter, P. J.
    Rye, K. A.
    Heather, A. K.
    Shearston, K. D.
    Rodgers, K. J.
    ATHEROSCLEROSIS, 2016, 251 : 39 - 46
  • [2] Effects of apolipoprotein A-IV genotype on glucose and plasma lipoprotein levels
    Larson, IA
    Ordovas, JM
    Sun, Z
    Barnard, JR
    Lohrmann, J
    Feussner, G
    Lamon-Fava, S
    Schaefer, EJ
    CLINICAL GENETICS, 2002, 61 (06) : 430 - 436
  • [3] Decreased plasma apolipoprotein A-IV levels in patients with acute coronary syndrome
    Li, Jiabei
    Song, Mingbao
    Qian, Dehui
    Lu, Wei
    Wang, Juan
    Jiang, Guoyan
    Jin, Jun
    Wu, Xiaojing
    Huang, Lan
    CLINICAL AND INVESTIGATIVE MEDICINE, 2013, 36 (04): : E207 - E215
  • [4] The relationship between plasma apolipoprotein A-IV levels and coronary heart disease
    Warner, MM
    Guo, JX
    Zhao, YM
    CHINESE MEDICAL JOURNAL, 2001, 114 (03) : 275 - 279
  • [5] Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice
    Ostos, MA
    Conconi, M
    Vergnes, L
    Baroukh, N
    Ribalta, J
    Girona, J
    Caillaud, JM
    Ochoa, A
    Zakin, MM
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (06) : 1023 - 1028
  • [6] Apolipoprotein A-IV: A potential therapeutic target for atherosclerosis
    Peng, Jia
    Li, Xiang-ping
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2018, 139 : 87 - 92
  • [7] Apolipoprotein E and A-IV diagnostic and functional aspects
    Baralle, FE
    Zakin, MM
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2002, 36 (04): : 495 - 503
  • [8] Distinctive structure and interfacial activity of the human apolipoprotein A-IV 347S isoprotein
    Weinberg, Richard B.
    Cook, Victoria R.
    JOURNAL OF LIPID RESEARCH, 2010, 51 (09) : 2664 - 2671
  • [9] Human leucine zipper protein promotes hepatic steatosis via induction of apolipoprotein A-IV
    Kang, Minsoo
    Kim, Jeonghan
    An, Hyoung-Tae
    Ko, Jesang
    FASEB JOURNAL, 2017, 31 (06) : 2548 - 2561
  • [10] Role of the kidney in the metabolism of apolipoprotein A-IV:: influence of the type of proteinuria
    Lingenhel, Arno
    Lhotta, Karl
    Neyer, Ulrich
    Heid, Iris M.
    Rantner, Barbara
    Kronenberg, Martina F.
    Koenig, Paul
    von Eckardstein, Arnold
    Schober, Maria
    Dieplinger, Hans
    Kronenberg, Florian
    JOURNAL OF LIPID RESEARCH, 2006, 47 (09) : 2071 - 2079